Cite Filings / TMCI / 0001172661-25-003633
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G/A

Statement of Beneficial Ownership

TREACE MEDICAL CONCEPTS, INC. · Filed 2025-08-15 · Acc 0001172661-25-003633

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2025-11-14 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-08-15 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-08-12 4 Chief Legl & Comp Off, CorpSec gave up 10,515 shares (to pay taxes)
  • 2025-08-12 4 Chief Financial Officer gave up 22,212 shares (to pay taxes)
  • 2025-08-12 4 Chief Innovation Officer gave up 9,814 shares (to pay taxes)
  • 2025-08-12 4 SVP, Sales gave up 4,907 shares (to pay taxes)
  • 2025-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · Armistice Capital, LLC 9.79%
  2. 2026-11-16 SCHEDULE 13G/A · Armistice Capital, LLC 1.96%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…